Understand what your gut health results really mean
See your biomarkers in context with a comprehensive panel.
- CLIA-certified labs
- HIPAA compliant
- Personalized health protocol
Bacteroides uniformis: A well-studied fiber fermenter
A Bacteroides uniformis test measures the abundance of a single, well‑studied gut bacterium from a small stool sample. Labs typically quantify this species using species‑specific quantitative PCR or shotgun metagenomic sequencing. Both methods analyze microbial DNA in stool to estimate how much B. uniformis is present relative to the total community, sometimes also reporting absolute copies per gram. While 16S rRNA profiling can describe the broader genus Bacteroides, precise species‑level calls usually rely on metagenomics or qPCR. Results capture your current ecosystem snapshot, which can shift with diet, medications, travel, stress, and illness.
Why this microbe matters: B. uniformis specializes in digesting complex carbohydrates from plants and produces beneficial short‑chain fatty acids that help fuel colon cells, reinforce the gut barrier, and modulate immune tone. Research links its presence to features of metabolic health and balanced inflammation, though effects vary by person and context. Think of it as one player in a larger orchestra—the whole microbiome determines the music—but this instrument often supports a steady rhythm.
What this species adds to your microbiome picture
In real life, you feel your microbiome at the dinner table and the day after. If your gut is light on microbes that thrive on fiber, you may experience sluggish digestion, more gas from fermentation happening in the “wrong” places, or signals of low‑grade inflammation. Measuring B. uniformis helps identify a pattern of dysbiosis where fiber‑degrading capacity is underpowered or, conversely, where a Bacteroides‑dominant profile aligns with high animal fat and low fermentable fiber intake. It also helps assess how recent antibiotics, restrictive dieting, or GI infections may have reshaped your microbial community. This test is especially useful after major dietary shifts, persistent GI symptoms, or when you and your clinician are exploring microbiome contributions to weight, glucose control, or skin flares.
Zooming out, the microbiome influences glucose regulation, lipid metabolism, bile acid recycling, and immune signaling that affects everything from workout recovery to how your skin reacts to stress. Short‑chain fatty acids produced by fiber‑friendly microbes can nudge gut hormones that regulate appetite and glucose, a pathway that overlaps with mechanisms people hear about in the GLP‑1 conversation, though microbiome effects are gentler and require consistent inputs from diet. Repeating microbiome testing over time turns isolated numbers into patterns, showing whether the ecosystem is resilient or easily disrupted. The aim is not to chase a single “perfect” microbe but to understand how your B. uniformis level fits into your broader microbial signature to guide prevention and long‑term wellness.
Test 100+ biomarkers from home
One blood draw. A full picture of your health, explained in plain language.
Test 100+ biomarkers from home
One blood draw. A full picture of your health, explained in plain language.
Reading your B. Uniformis number
Your report typically shows Bacteroides uniformis as a relative abundance percentage and, in some labs, as absolute copies per gram of stool. Many reports compare your values to a reference population to indicate whether your level is lower, typical, or higher than peers. There is no universal “gold standard” range for this species, so interpretations depend on the lab’s method and reference set. In general, balanced microbiomes often feature a moderate presence of B. uniformis alongside good overall diversity and representation of other beneficial groups. That pattern tends to align with efficient fiber breakdown, steady short‑chain fatty acid output, and a calm mucosal immune environment.
If your level is on the lower side, it can suggest reduced capacity to process certain plant polysaccharides, which may correlate with symptoms like irregularity or a tendency toward fluctuating stool texture. If it is relatively high, it may reflect a Bacteroides‑leaning profile often seen with higher fat and protein intake and lower fermentable fiber, though individuals vary widely. Either way, the result is a clue rather than a diagnosis. It points to functional patterns—how your gut community uses the foods you give it—that may be explored with nutrition strategies or clinical evaluation if symptoms persist.
Day-to-day factors that move the number
Context matters. Stool consistency, recent meals, transit time, travel, probiotics, and antibiotics in the last 1–2 months can shift levels. Different assays can yield different numbers, so trends over time in the same lab are more meaningful than any single value. For a fuller picture, consider how your B. uniformis result aligns with other data, such as fecal calprotectin or lactoferrin for inflammation, bile acid markers, or systemic labs like A1C and triglycerides. Emerging studies associate B. uniformis with favorable metabolic and inflammatory profiles, but individual responses differ and more human research is needed. The most useful takeaway is how this species fits into your unique ecosystem and health story today.
Frequently Asked Questions
References
- Gauffin Cano P, Santacruz A, Moya, Á., Sanz Y (2012). Bacteroides uniformis CECT 7771 ameliorates metabolic and immunological dysfunction in mice with high-fat-diet induced obesity. *PLoS One*, *7*(7), e41079. https://doi.org/10.1371/journal.pone.0041079
- El Kaoutari A, Armougom F, Gordon JI, Raoult D, Henrissat B (2013). The abundance and variety of carbohydrate-active enzymes in the human gut microbiota. *Nature Reviews Microbiology*, *11*(7), 497-504. https://doi.org/10.1038/nrmicro3050
- Koh A, De Vadder F, Kovatcheva-Datchary P, Bäckhed F (2016). From dietary fiber to host physiology: Short-chain fatty acids as key bacterial metabolites. *Cell*, *165*(6), 1332-1345. https://doi.org/10.1016/j.cell.2016.05.041
- Lynch SV, Pedersen O (2016). The human intestinal microbiome in health and disease. *The New England Journal of Medicine*, *375*(24), 2369-2379. https://doi.org/10.1056/NEJMra1600266
- Porcari S, Mullish BH, Asnicar F, Ng SC, Zhao L, Hansen R, O'Toole PW, Raes J, Hold G, Putignani L, Gasbarrini A, Segata N, Cammarota G (2025). International consensus statement on microbiome testing in clinical practice. *The Lancet Gastroenterology & Hepatology*, *10*(2), 154-167. https://doi.org/10.1016/S2468-1253(24)00311-X















